Manufactor:Bigbear Pharmaceutical Laos
Introduction:Trelagliptin was approved for marketing in Japan on March 26, 2015. It is an ultra-long-acting dipeptidyl peptidase IV (DPP-4) inhibitor that can effectively control blood sugar by taking one pill per week.
【Drug Name】
Name: Trelagliptin Tablets
Product Name: TEGLIDX
【Specification】
100mg
【Indications】
• TEGLIDX is a dipeptidyl peptidase-4 inhibitor indicated in the control of type 2 diabetes mellitus.
【Recommended Dosage】
• TakeTEGLIDX exactly as your healthcare provider tells you to.
• Usually, for adults, 100 mg of trelagliptin is orally administered once a week. The score line is not intended for dose adjustment. Do not break or crush the tablet.
【Side Effects】
• Hypersensitivity to trilagliptin or any of its components; Patients with severe renal impairment or end-stage renal failure on dialysis. Hypoglycemia: The risk of hypoglycemia may be increased by concomitant use of tregliptin and sulfonylureas or insulin preparations.
• Hypersensitivity (rash, pruritus), atrial fibrillation, liver (increased ALT, AST, – increased GTP), urinary blood positive, nasopharyngitis, increased lipase, increased amylase.
【Storage】
Store below 30ºC
Keep TEGLIDX and all medicines out of reach of children.